The 3,30,5,50-tetrachloro-2-iodo-4,40-bipyridine structure is proposed as a novel chemical scaold for the design of new transthyretin (TTR) fibrillogenesis inhibitors. In the frame of a proof-of-principle exploration, four chiral 3,30,5,50-tetrachloro-2-iodo-20-substituted-4,40- bipyridines were rationally designed and prepared from a simple trihalopyridine in three steps, including a Cu-catalysed Finkelstein reaction to introduce iodine atoms on the heteroaromatic scaold, and a Pd-catalysed coupling reaction to install the 20-substituent. The corresponding racemates, along with other five chiral 4,40-bipyridines containing halogens as substituents, were enantioseparated by high-performance liquid chromatography in order to obtain pure enantiomer pairs. All stereoisomers were tested against the amyloid fibril formation (FF) of wild type (WT)-TTR and two mutant variants, V30M and Y78F, in acid mediated aggregation experiments. Among the 4,40-bipyridine derivatives, interesting inhibition activity was obtained for both enantiomers of the 3,30,5,50-tetrachloro-20-(4-hydroxyphenyl)-2-iodo-4,40-bipyridine. In silico docking studies were carried out in order to explore possible binding modes of the 4,40-bipyridine derivatives into the TTR. The gained results point out the importance of the right combination of H-bond sites and the presence of iodine as halogen-bond donor. Both experimental and theoretical evidences pave the way for the utilization of the iodinated 4,40-bipyridine core as template to design new promising inhibitors of TTR amyloidogenesis.

Rational Design, Synthesis, Characterization and Evaluation of Iodinated 4,4′-Bipyridines as New Transthyretin Fibrillogenesis Inhibitors

Cossu, Sergio
Funding Acquisition
2020

Abstract

The 3,30,5,50-tetrachloro-2-iodo-4,40-bipyridine structure is proposed as a novel chemical scaold for the design of new transthyretin (TTR) fibrillogenesis inhibitors. In the frame of a proof-of-principle exploration, four chiral 3,30,5,50-tetrachloro-2-iodo-20-substituted-4,40- bipyridines were rationally designed and prepared from a simple trihalopyridine in three steps, including a Cu-catalysed Finkelstein reaction to introduce iodine atoms on the heteroaromatic scaold, and a Pd-catalysed coupling reaction to install the 20-substituent. The corresponding racemates, along with other five chiral 4,40-bipyridines containing halogens as substituents, were enantioseparated by high-performance liquid chromatography in order to obtain pure enantiomer pairs. All stereoisomers were tested against the amyloid fibril formation (FF) of wild type (WT)-TTR and two mutant variants, V30M and Y78F, in acid mediated aggregation experiments. Among the 4,40-bipyridine derivatives, interesting inhibition activity was obtained for both enantiomers of the 3,30,5,50-tetrachloro-20-(4-hydroxyphenyl)-2-iodo-4,40-bipyridine. In silico docking studies were carried out in order to explore possible binding modes of the 4,40-bipyridine derivatives into the TTR. The gained results point out the importance of the right combination of H-bond sites and the presence of iodine as halogen-bond donor. Both experimental and theoretical evidences pave the way for the utilization of the iodinated 4,40-bipyridine core as template to design new promising inhibitors of TTR amyloidogenesis.
File in questo prodotto:
File Dimensione Formato  
2020 molecules-25-02213-v2.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 3.04 MB
Formato Adobe PDF
3.04 MB Adobe PDF Visualizza/Apri

I documenti in ARCA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10278/3726078
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact